Regulatory Developments in the Life Sciences Sector and How it Impacts Life Sciences Companies

Join us for a discussion on regulatory developments relating to clinical trials in the Life Sciences sector. Topics include:

• Changes to the Regulatory Landscape for Clinical Trials
• Ensuring Diversity in Clinical Trials
• Conducting Clinical Trials Remotely
• Additional Challenges for Rare Disease Clinical Trials
• Ensuring Compliance and Data Integrity
• How Clinical Trials affect Representations and Warranties in M&A and Investment Deals
• IPO preparedness for companies with clinical trials

CLE is not available when viewing a recording of this program. In order to receive credit you must have attended the live webinar program.